They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
|
|
- Sophia Miles
- 6 years ago
- Views:
Transcription
1 Managing neutropenic sepsis in secondary and tertiary care bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: NICE Pathway last updated: 30 August 2017 This document contains a single flowchart and uses numbering to link the boxes to the associated recommendations. Page 1 of 10
2 Page 2 of 10
3 1 Person with suspected neutropenic sepsis No additional information 2 Emergency treatment and assessment Treat suspected neutropenic sepsis as an acute medical emergency and offer empiric antibiotic therapy immediately. Include in the initial clinical assessment of patients with suspected neutropenic sepsis: history and examination full blood count, kidney and liver function tests (including albumin), C-reactive protein, lactate and blood culture. See what NICE says on acutely-ill patients in hospital and acute kidney injury. Further assessment After completing the initial clinical assessment (see above) try to identify the underlying cause of the sepsis by carrying out: additional peripheral blood culture in patients with a central venous access device if clinically feasible urinalysis in all children aged under 5 years. Do not perform a chest X-ray unless clinically indicated. Tests for rapidly identifying bloodstream bacteria and fungi The following recommendations are from NICE diagnostics guidance on tests for rapidly identifying bloodstream bacteria and fungi (LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay). There is currently insufficient evidence to recommend the routine adoption in the NHS of the LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi. The tests show promise and further research to provide robust evidence is encouraged, particularly to demonstrate the value of using the test results in clinical decision-making (see sections 5.18 to 5.22 of NICE diagnostics guidance 20). Page 3 of 10
4 NICE has published a medtech innovation briefing on Fungitell for antifungal treatment stratification. Procalcitonin testing The following recommendations are from NICE diagnostics guidance on procalcitonin testing for diagnosing and monitoring sepsis. The procalcitonin tests (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay or VIDAS BRAHMS PCT assay) show promise but there is currently insufficient evidence to recommend their routine adoption in the NHS. Further research on procalcitonin tests is recommended for guiding decisions to: stop antibiotic treatment in people with confirmed or highly suspected sepsis in the intensive care unit or start and stop antibiotic treatment in people with suspected bacterial infection presenting to the emergency department. Centres currently using procalcitonin tests to guide these decisions are encouraged to participate in research and data collection (see section 6.25 of NICE diagnostics guidance 18). 3 Start antibiotic therapy All patients Offer beta lactam monotherapy with piperacillin with tazobactam 1 as initial empiric antibiotic therapy to patients with suspected neutropenic sepsis who need intravenous treatment unless there are patient-specific or local microbiological contraindications. Do not offer an aminoglycoside, either as monotherapy or in dual therapy, for the initial empiric treatment of suspected neutropenic sepsis unless there are patient-specific or local microbiological indications. Empiric glycopeptide antibiotics in patients with central venous access devices Do not offer empiric glycopeptide antibiotics to patients with suspected neutropenic sepsis who have central venous access devices unless there are patient-specific or local microbiological indications. Page 4 of 10
5 1 At the time this guidance was created (September 2012) piperacillin with tazobactam did not have a UK marketing authorisation for use in children aged under 2 years. The prescriber should follow relevant professional guidance, taking full responsibility for the decision. The child's parent or carer should provide informed consent, which should be documented. See the General Medical Council's Good practice in prescribing and managing medicines and devices and the prescribing advice provided by the Joint Standing Committee on Medicines (a joint committee of the Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group) for further information. Page 5 of 10
6 Do not remove central venous access devices as part of the initial empiric management of suspected neutropenic sepsis. 4 Confirm diagnosis of neutropenic sepsis Diagnose neutropenic sepsis in patients having anticancer treatment whose neutrophil count is per litre or lower and who have either: a temperature higher than 38 C or other signs or symptoms consistent with clinically significant sepsis. 5 Assess the patient's risk of septic complications A healthcare professional with competence in managing complications of anticancer treatment should assess the patient's risk of septic complications within 24 hours of presentation to secondary or tertiary care, basing the risk assessment on presentation features and using a validated risk scoring system. Examples of risk scoring systems include the Multinational Association of Supportive Care in Cancer risk index and the modified Alexander rule for children. 6 Patient at low risk of septic complications Consider outpatient antibiotic therapy for patients with confirmed neutropenic sepsis and a low risk of developing septic complications, taking into account the patient's social and clinical circumstances and discussing with them the need to return to hospital promptly if a problem develops. 7 Patient at high risk of septic complications For patients with confirmed neutropenic sepsis and a high risk of developing septic complications, a healthcare professional with competence in managing complications of anticancer treatment should daily: review the patient's clinical status reassess the patient's risk of septic complications, using a validated risk scoring system. Examples of risk scoring systems include the Multinational Association of Supportive Care in Cancer risk index and the modified Alexander rule for children. Page 6 of 10
7 Do not switch initial empiric antibiotics in patients with unresponsive fever unless there is clinical deterioration or a microbiological indication. 8 Patient whose risk of septic complications is reassessed as low Switch from intravenous to oral antibiotic therapy after 48 hours of treatment in patients whose risk of developing septic complications has been reassessed as low by a healthcare professional with competence in managing complications of anticancer treatment using a validated risk scoring system. Examples of risk scoring systems include the Multinational Association of Supportive Care in Cancer risk index and the modified Alexander rule for children. Consider outpatient antibiotic therapy for patients with confirmed neutropenic sepsis and a low risk of developing septic complications, taking into account the patient's social and clinical circumstances and discussing with them the need to return to hospital promptly if a problem develops. 9 Duration of antibiotic treatment Continue inpatient empiric antibiotic therapy in all patients who have unresponsive fever unless an alternative cause of fever is likely. Discontinue empiric antibiotic therapy in patients whose neutropenic sepsis has responded to treatment, irrespective of neutrophil count. 10 Discharge Offer discharge to patients having empiric antibiotic therapy for neutropenic sepsis only after: the patient's risk of developing septic complications has been reassessed as low by a healthcare professional with competence in managing complications of anticancer treatment using a validated risk scoring system and taking into account the patient's social and clinical circumstances and discussing with them the need to return to hospital promptly if a problem develops. Examples of risk scoring systems include the Multinational Association of Supportive Care in Cancer risk index and the modified Alexander rule for children. Page 7 of 10
8 Glossary Anticancer treatment given with the intent to reduce the level of cancer cells in a patient; it includes, but is not limited to, chemotherapy and radiotherapy Empiric an action undertaken prior to determination of the underlying cause of a problem Empiric antibiotic given to a person before a specific microorganism or source of the potential infection is known; it is usually a broad-spectrum antibiotic and the treatment may change if the microorganism or source is confirmed Empiric antibiotics given to a person before a specific microorganism or source of the potential infection is known; they are usually broad-spectrum antibiotics and the treatment may change if the microorganism or source is confirmed G-CSF granulocyte-colony stimulating factor; a type of protein that stimulates the bone marrow to make white blood cells (granulocytes) Sources : prevention and management in people with cancer (2012) NICE guideline CG151 Tests for rapidly identifying bloodstream bacteria and fungi (LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay) (2016) NICE diagnostics guidance 20 Procalcitonin testing for diagnosing and monitoring sepsis (2015) NICE diagnostics guidance 18 Page 8 of 10
9 Your responsibility Guidelines The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian. Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Technology appraisals The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this interactive flowchart is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Commissioners and/or providers have a responsibility to provide the funding required to enable the recommendations to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to Page 9 of 10
10 have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Medical technologies guidance, diagnostics guidance and interventional procedures guidance The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take these recommendations fully into account. However, the interactive flowchart does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer. Commissioners and/or providers have a responsibility to implement the recommendations, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Page 10 of 10
They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
overview bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Managing pressure ulcers in neonates, infants, children and young people bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationQuality standard Published: 16 July 2013 nice.org.uk/guidance/qs36
Urinary tract infection in children and young people Quality standard Published: 16 July 2013 nice.org.uk/guidance/qs36 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationSepsis guidance implementation advice for adults
Sepsis guidance implementation advice for adults NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Strategy & Innovation
More informationPublic health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36
Healthcare-associated infections: prevention ention and control Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 NICE 2017. All rights reserved. Subject to Notice of rights
More informationUHBristol Trustwide Neutropenic Sepsis Audit. Krishna Garadi Julia Hardwick Ruth Hendy Anna Kuchel Tara Shine Sam Wells
UHBristol Trustwide Neutropenic Sepsis Audit Krishna Garadi Julia Hardwick Ruth Hendy Anna Kuchel Tara Shine Sam Wells Background Cancer Peer Review measure for Acute Oncology Door to needle time for suspected
More informationNHS Rushcliffe CCG Governing Body Meeting. CCG Improvement and Assurance Framework. 15 March 2018
RCCG/GB/18/039 NHS Rushcliffe CCG Governing Body Meeting 15 March 2018 Introduction 1. This paper provides the Governing Body with an update on the progress being made by the Greater Nottingham CCGs in
More informationNICE guideline Published: 22 September 2017 nice.org.uk/guidance/ng74
Intermediate care including reablement NICE guideline Published: 22 September 2017 nice.org.uk/guidance/ng74 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. 170008/S Service Atypical haemolytic uraemic syndrome (ahus) (all ages) Commissioner Lead Provider Lead Period Date of Review
More informationAnti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted
More informationSpecialised Services Service Specification: Inherited Bleeding Disorders
Specialised Services Service Specification: Inherited Bleeding Disorders Document Author: Assistant Specialised Services Planner Cardiac and Cancer Specialised Services Planner Cancer and Blood Executive
More informationImprovement and Assessment Framework Q1 performance and six clinical priority areas
Governing Body 30 th September 2016 Improvement and Assessment Framework Q1 performance and six clinical priority areas Agenda item 16 Paper 10 Summariser: Authors and contributors: Executive Lead(s):
More informationClinical guideline Published: 25 July 2007 nice.org.uk/guidance/cg50
Acutely ill adults in hospital: recognising and responding to deterioration Clinical guideline Published: 25 July 2007 nice.org.uk/guidance/cg50 NICE 2018. All rights reserved. Subject to Notice of rights
More information21 March NHS Providers ON THE DAY BRIEFING Page 1
21 March 2018 NHS Providers ON THE DAY BRIEFING Page 1 2016-17 (Revised) 2017-18 (Revised) 2018-19 2019-20 (Indicative budget) 2020-21 (Indicative budget) Total revenue budget ( m) 106,528 110,002 114,269
More informationAdmissions with neutropenic sepsis in adult, general critical care units in England, Wales and Northern Ireland
Admissions with neutropenic sepsis in adult, general critical care units in England, Wales and Northern Ireland Question What were the: age; gender; APACHE II score; ICNARC physiology score; critical care
More informationCompetency Asse ssment Tool for Care of Febrile Neutropenia 2009
Competency Asse ssment Tool for Care of Febrile Neutropenia 2009 Guidelines for use: In assessing competence, a combination of assessment methods may be utilised including clinical questioning/ interview
More informationOverview. Dr Stephen Gulliford & AKI Specialist Nurse Suzanne Wilson Page 1
Improving Patient Safety and Reducing Harm through the Development of an Acute Kidney Injury Specialist Service at Wrightington, Wigan and Leigh NHS Foundation Trust Overview Acute Kidney Injury (AKI)
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationAssessment of Appropriateness of ICU Antibiotics (Hospital Level Sheet) PQC, Revised 02/16/2017
Assessment of Appropriateness of Antibiotics (Hospital Level Sheet) PQC, Revised 02/16/2017 For this assessment, antibiotic use is defined as receiving when it is not necessary, not making timely adjustments
More informationAintree University Hospital NHS Foundation Trust Corporate Strategy
Aintree University Hospital NHS Foundation Trust Corporate Strategy 2015 2020 Aintree University Hospital NHS Foundation Trust 1 SECTION ONE: BACKGROUND AND CONTEXT 1 Introduction Aintree University Hospital
More informationClinical guideline Published: 23 April 2008 nice.org.uk/guidance/cg65
Hypothermia: prevention ention and management in adults having surgery Clinical guideline Published: 23 April 2008 nice.org.uk/guidance/cg65 NICE 20. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationYour referral to the Haematology Team
Mid Cheshire Hospitals NHS Foundation Trust NHS Your referral to the Haematology Team INFORMATION FOR PATIENTS AND CARERS www.mcht.nhs.uk Our Hospitals, Our Future Your referral to the Haematology Team
More informationUniversity College Hospital. The Myeloma Cancer Multi-Disciplinary Team. University College Hospital Macmillan Cancer Centre
University College Hospital The Myeloma Cancer Multi-Disciplinary Team University College Hospital Macmillan Cancer Centre 1 Contents Page 1. Introduction 2 2. Medical teams 3 3. Key Worker 3 4. Clinical
More informationClinical guideline Published: 23 July 2008 nice.org.uk/guidance/cg69
Respiratory tract infections (self- limiting): prescribing antibiotics Clinical guideline Published: 23 July 08 nice.org.uk/guidance/cg69 NICE 18. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationCommissioning for Quality & Innovation (CQUIN)
Commissioning for Quality & Innovation () The following suite of s are goals relating to improvements in the quality of patient care which the Trust has agreed with commissioners (with the exception of
More informationHealthcare associated infections across the health and social care community
Healthcare associated infections across the health and social care community Professor Brian Duerden CBE Inspector of Microbiology and Infection Control, Department of Health, London Infection is different..it
More informationPrevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
More informationCommissioning for Quality and Innovation (CQUIN) Guidance for 2016/17 Published March 2016
Commissioning for Quality and Innovation (CQUIN) Guidance for 2016/17 Published March 2016 Commissioning for Quality and Innovation (CQUIN) Introduction1 The CQUIN scheme is intended to deliver clinical
More informationSpecialised Services Commissioning Policy: CP160 Specialised Paediatric Neurological Rehabilitation
Specialised Services Commissioning Policy: CP160 Specialised Paediatric Neurological Rehabilitation April 2018 Version 4.0 Document information Document purpose Document name Author Policy Specialised
More informationThe Myeloma Nursing Competency Framework
The Myeloma Nursing Competency Framework 2 Contents Using the Framework Section one: KSF dimensions and myeloma-specific skills and knowledge 8 Competency Assessment Form 12 Section two: Core nursing competencies
More informationHospital Outpatient Quality Measures. Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: January, 2018
Hospital Outpatient Quality Measures Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: January, 2018 Background Hospitals have separate quality measures for the outpatient population. These measures
More informationNurse prescribing in Cancer Care. Emma Sweeney MSc BSc (Hons) RN Macmillan Head of Cancer Nursing Colchester Hospital University Trust
Nurse prescribing in Cancer Care Emma Sweeney MSc BSc (Hons) RN Macmillan Head of Cancer Nursing Colchester Hospital University Trust Objectives Supporting non medical prescribers: discuss the infrastructure
More information*Your Name *Nursing Facility. radiation therapy. SECTION 2: Acute Change in Condition and Factors that Contributed to the Transfer
Gaining information about resident transfers is an important goal of the OPTIMISTC project. CMS also requires us to report these data. This form is where data relating to long stay transfers are to be
More informationMedical technologies guidance Published: 21 March 2018 nice.org.uk/guidance/mtg37
Thopaz+ portable digital system for managing chest drains Medical technologies guidance Published: 21 March 2018 nice.org.uk/guidance/mtg37 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationCERTIFICATE OF COMPLETION OF PAEDIATRIC LEVEL 1 COMPETENCY V1.0
Applicants applying for ST4 posts in paediatrics may use this certificate to successful, satisfactory completion of Level 1 paediatric competences, as defined in the RCPCH Level 1 Paediatrics and Child
More informationPerioperative management of the higher risk surgical patient with an acute surgical abdomen undergoing emergency surgery
CLINICAL GUIDELINE Perioperative management of the higher risk surgical patient with an acute surgical abdomen undergoing emergency surgery CG10214-2 For use in (clinical areas): For use by (staff groups):
More informationAcutely ill patients in hospital
Issue date: July 2007 Acutely ill patients in hospital Recognition of and response to acute illness in adults in hospital Developed by the Centre for Clinical Practice at NICE Contents Key priorities for
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement Programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationCancer Drugs Fund. Managed Access Agreement. Daratumumab monotherapy for treating relapsed and refractory multiple myeloma
Cancer Drugs Fund Managed Access Agreement Daratumumab monotherapy for treating relapsed and refractory multiple myeloma NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Cancer Drugs Fund Data Collection
More informationASCO s Quality Training Program
ASCO s Quality Training Program Project Title: Treatment of febrile neutropenia at the University of Virginia Presenter s Name: Tri Le, MD, Tanya Thomas, RN, Michael Keng, MD Institution: University of
More informationSeven Day Services Clinical Standards September 2017
Seven Day Services Clinical Standards September 2017 11 September 2017 Gateway reference: 06408 Patient Experience 1. Patients, and where appropriate families and carers, must be actively involved in shared
More informationHow NICE clinical guidelines are developed
Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine-Doxorubicin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationChildren s Community Nursing Team Chemotherapy Policy
Children s Community Nursing Team Chemotherapy Policy 1 Policy : Children s Community Nursing Team Chemotherapy Policy Executive Summary The purpose of this document is to set out guidance for the safe
More informationFinal scope for the systematic review of the clinical and cost effectiveness evidence for the prevention of ventilator-associated pneumonia (VAP)
Final scope for the systematic review of the clinical and cost effectiveness evidence for the prevention of ventilator-associated pneumonia (VAP) Contents 1. AIM...2 2. BACKGROUND...2 3. INTERVENTIONS...3
More informationPresenters. Tiffany Osborn, MD, MPH. Laura Evans, MD MSc. Arjun Venkatesh, MD, MBA, MHS
Sepsis Wave II New recommendations from the Surviving Sepsis Campaign and what do they mean for the ED How to use the E-QUAL Portal and submit Activity 2 Presenters Laura Evans, MD MSc Tiffany Osborn,
More informationSetting up and running a community IV therapy clinic
Setting up and running a community IV therapy clinic Moving care to the community has been a UK-wide health and social care priority for more than a decade (Royal College of Nursing [RCN], 2013). With
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine-Cisplatin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationNICE guideline Published: 25 May 2016 nice.org.uk/guidance/ng47
Haematological cancers: improving outcomes NICE guideline Published: 25 May 2016 nice.org.uk/guidance/ng47 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationCore competencies for the care of acutely ill and injured children and young people. May 2006
Core competencies for the care of acutely ill and injured children and young people May 2006 Contents Introduction 3 How the competencies can be used 6 Core competencies : Assessment domain 7 Core competencies
More informationCMS and NHSN: What s New for Infection Preventionists in 2013
CMS and NHSN: What s New for Infection Preventionists in 2013 Joan Hebden RN, MS, CIC Clinical Program Manager Sentri7 Wolters Kluwer Health - Clinical Solutions Objectives Define the current status of
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationChemotherapy Training and Assessment Framework for Registered Nurses
Chemotherapy Training and Assessment Framework for Registered Nurses Document Control Prepared By Issue Date Approved By Review Date Version Contributors Comments/ Amendment Jane Beveridge January 2012
More informationCare of Your Peripherally Inserted Central Catheter
Care of Your Peripherally Inserted Central Catheter A guide for patients and their carers Acute Oncology Patient Information Leaflet Contents Information for patients: What is a PICC? How is it put in?
More informationIntegrated heart failure service working across the hospital and the community
Integrated heart failure service working across the hospital and the community Lynne Ruddick Professional Lead (South) British Heart Foundation 31st October 2017 Heart Failure is an epidemic. NICE has
More informationAgenda Item: REPORT TO PUBLIC BOARD MEETING 31 May 2012
Agenda Item: 5.1.1 REPORT TO PUBLIC BOARD MEETING 31 May 2012 Title Lead Director Author(s) Purpose Previously considered by Ratification of the Strategy for the Care of Older People Siobhan Jordan, Director
More informationClinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2
GUIDANCE AND RECOMMENDATIONS Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2 This document provides
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination
More informationNeutropenic sepsis: NICE guidance
Neutropenic sepsis: NICE guidance Neutropenic sepsis statistics This is a potentially fatal complication of chemotherapy treatment. Mortality is 2 21%. Mortality has improved with rapid administration
More informationReferral to Treatment (RTT) Access Policy
General Referral to Treatment (RTT) Access Policy This is a controlled document and whilst this document may be printed, the electronic version posted on the intranet/shared drive is the controlled copy.
More informationPediatric Neonatology Sub I
Course Goals Goals 1. Provide patient care that is compassionate, appropriate and effective for the treatment of health problems. 2. Recommend and interpret common diagnostic tests and vital signs. 3.
More informationDRAFT Optimal Care Pathway
DRAFT Optimal Care Pathway 1. Introduction... 3 1.1 Background... 3 1.2 Intent of the Optimal Care Pathways... 3 1.3 Key principles of care... 3 2. Steps in the care of patients with x cancer... 4 Step
More informationResource impact report: End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61)
Putting NICE guidance into practice Resource impact report: End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61) Published: December 2016
More informationAttending Physician Statement- Major organ / Bone marrow transplantation
Instruction to doctor: This patient is insured with us against the happening of certain contingent events associated with his health. A claim has been submitted in connection with Major organ / Bone marrow.
More informationAcute kidney injury Keeping kidneys healthy: The AKI programme board. Dr Richard Fluck, National Clinical Director (Renal) NHS England
Acute kidney injury Keeping kidneys healthy: The AKI programme board Dr Richard Fluck, National Clinical Director (Renal) NHS England NHS Outcomes Framework NHS Five Year Forward View A vision for the
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationTherapeutic Apheresis Services Service Portfolio
Therapeutic Apheresis Services Service Portfolio 29150_006rm_Therapeutic Apheresis Services-V2.indd 1 20/03/2018 11:46 Contents Therapeutic Apheresis Services 2 Our Facilities 3 Procedure Portfolio 4
More informationBristol CCG North Somerset CGG South Gloucestershire CCG. Draft Commissioning Intentions for 2017/2018 and 2018/2019
Bristol CCG North Somerset CGG South Gloucestershire CCG Draft Commissioning Intentions for 2017/2018 and 2018/2019 Programme Area Key intention Primary and community care Sustainable primary care Implement
More information2017/18 and 2018/19 National Tariff Payment System Annex E: Guidance on currencies without national prices. NHS England and NHS Improvement
2017/18 and 2018/19 National Tariff Payment System Annex E: Guidance on currencies without national prices NHS England and NHS Improvement December 2016 Contents 1. Introduction... 3 2. Critical care adult
More informationAntimicrobial stewardship in Scotland: quality improvement agenda
Antimicrobial stewardship in Scotland: quality improvement agenda Dr Jacqueline Sneddon Project Lead Scottish Antimicrobial Prescribing Group Background Scottish Antimicrobial Prescribing Group (SAPG)
More informationNICE guideline Published: 17 September 2015 nice.org.uk/guidance/ng21
Home care: delivering ering personal care and practical support to older people living in their own homes NICE guideline Published: 17 September 2015 nice.org.uk/guidance/ng21 NICE 2018. All rights reserved.
More informationRecognising a Deteriorating Patient. Study guide
Recognising a Deteriorating Patient Study guide Recognising a deteriorating patient Recognising and responding to clinical deterioration Background Clinical deterioration can occur at any time in a patient
More informationIndependent investigation into the death of Mr Jeffrey Rookes a prisoner at HMP Erlestoke on 14 June 2017
Independent investigation into the death of Mr Jeffrey Rookes a prisoner at HMP Erlestoke on 14 June 2017 Crown copyright 2017 This publication is licensed under the terms of the Open Government Licence
More informationThe non-executive director s guide to NHS data Part one: Hospital activity, data sets and performance
Briefing October 2017 The non-executive director s guide to NHS data Part one: Hospital activity, data sets and performance Key points As a non-executive director, it is important to understand how data
More informationPATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title
Patient identifier/label: Page 1 of 5 GENERIC CONSENT FORM Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number (or other identifier) Male Female Special requirements
More informationClinical Strategy
Clinical Strategy 2012-2017 www.hacw.nhs.uk CLINICAL STRATEGY 2012-2017 Our Clinical Strategy describes how we are going to deliver high quality care in response to patient and carer feedback and commissioner
More informationAction on sepsis: Publishing a cross-system action plan
Action on sepsis: Publishing a cross-system action plan Purpose 1. The profile of sepsis (caused by the body s immune response to a bacterial or fungal infection - a time-critical condition that can lead
More informationICD-9 (Diagnosis) Coding
1 Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur without the permission of Tulane University.
More informationDRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service
DRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service Executive summary: The Cornwall Sustainability and Transformation Plan known as Shaping our Future will describe a new model of
More informationSepsis The Silent Killer in the NHS
Sepsis The Silent Killer in the NHS Kate Beaumont, Trustee, UK Sepsis Trust Nurse Director The Learning Clinic Director QGi Ltd Former Head of Patient Safety and lead for deterioration, National Patient
More informationPaignton and Brixham Locality Development
Paignton and Brixham Locality Development Contents Population Pressures Slide 2 Current Use of Services Slide 11 Financial Pressures Slide 15 The Case for Change Slide 20 Into the Future Slide 23 How to
More informationColorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements
6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services
More informationSPSP: Sepsis in Primary Care Collaborative. Dr Paul Davidson Associate Medical Director Primary Care NHS Highland
SPSP: Sepsis in Primary Care Collaborative Dr Paul Davidson Associate Medical Director Primary Care NHS Highland Collaborative Ambition Improve early recognition and timely delivery of evidence-based interventions,
More informationNational clinical audit of inpatient care for adults with ulcerative colitis
National clinical audit of inpatient care for adults with ulcerative colitis UK inflammatory bowel disease (IBD) audit Executive summary report June 2014 Prepared by the Clinical Effectiveness and Evaluation
More informationEssentials for Clinical Documentation Integrity 2017
Essentials for Clinical Documentation Integrity 2017 Prepared and Published By: MedLearn Publishing A Division of Panacea Healthcare Solutions, Inc. 287 East Sixth Street, Suite 400 St. Paul, MN 55101
More informationIf you have an. invasive fungal infection. Why did I get it? What is it? What should I do? What can I expect? INFORMATION FOR YOU AND YOUR FAMILY
INFORMATION FOR YOU AND YOUR FAMILY my UNDERSTANDING invasive fungal infection If you have an invasive fungal infection What is it? Why did I get it? What can I expect? What should I do? Inside this brochure
More informationProcess and definitions for the daily situation report web form
Process and definitions for the daily situation report web form November 2017 The daily situation report (sitrep) indicates where there are pressures on the NHS around the country in areas such as breaches
More informationGUIDELINE FOR THE MANAGEMENT OF SUSPECTED NEUTROPENIC SEPSIS INDUCED BY CYTOTOXIC THERAPY
GUIDELINE FOR THE MANAGEMENT OF SUSPECTED NEUTROPENIC SEPSIS INDUCED BY CYTOTOXIC THERAPY This guidance does not override the individual responsibility of health professionals to make appropriate decision
More informationCommissioning Policy
Commissioning Policy Consultant to Consultant Referrals Version 6.0 December 2017 Name of Responsible Board / Committee for Ratification: North Staffordshire CCG Stoke on Trent CCG Date Issued: November
More informationReducing HCAI- What the Commissioner needs to know.
Reducing HCAI- What the Commissioner needs to know. Sarah Mantle HCAI/AMR project lead NHS England #NHSEngAMR Do Tweet Introduction Healthcare Associated Infections (HCAI) can develop as a result of direct
More information'Think Kidneys': Improving the management of acute kidney injury in the NHS
WELCOME TO THIS SIGN UP TO SAFETY WEBINAR 'Think Kidneys': Improving the management of acute kidney injury in the NHS All participants lines are muted to reduce background noise Acute Kidney Injury National
More informationClinical Check of Prescriptions in Ward Areas
Pharmacy Department Standard Operating Procedures SOP Title Clinical Check of Prescriptions in Ward Areas Author name and Gareth Price designation: Deputy Director of Pharmacy Clinical Services Pharmacy
More informationAntimicrobial Stewardship in Continuing Care. Nursing Home Acquired Pneumonia Clinical Checklist
Antimicrobial Stewardship in Continuing Care Nursing Home Acquired Pneumonia Clinical Checklist March 2015 What is Antimicrobial Stewardship? Using the: right antimicrobial agent for a given diagnosis
More informationUsing Electronic Health Records for Antibiotic Stewardship
Using Electronic Health Records for Antibiotic Stewardship STRENGTHEN YOUR LONG-TERM CARE STEWARDSHIP PROGRAM BY TRACKING AND REPORTING ELECTRONIC DATA Introduction Why Use Electronic Systems for Stewardship?
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust Venous. Thromboembolism (VTE) Assessment and Management
The Newcastle upon Tyne Hospitals NHS Foundation Trust Venous Thromboembolism (VTE) Assessment and Management Version No: 2.0 Effective From: 16 April 2018 Expiry Date: 16 April 2021 Date Ratified: 23
More informationJOB DESCRIPTION Safe, compassionate, effective care provided to our communities with a transparent, open approach.
JOB DESCRIPTION Safe, compassionate, effective care provided to our communities with a transparent, open approach. JOB TITLE: GRADE: BASE: MANAGED BY: Advanced Neonatal Nurse Practitioner Band 8a Homerton
More informationEnd of Life Care Strategy
End of Life Care Strategy 2016-2020 Foreword Southern Health NHS Foundation Trust is committed to providing the highest quality care for patients, their families and carers. Therefore, I am pleased to
More informationCommissioning for Quality and Innovation (CQUIN) Schemes for 2015/16
Commissioning for Quality and Innovation (CQUIN) Schemes for 2015/16 Goal No. Indicator Name Contract 1 Acute Kidney Injury CWS CCG Contract - National CQUIN 2a Sepsis Screening CWS CCG Contract - National
More informationSAFE STAFFING GUIDELINE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline title SAFE STAFFING GUIDELINE SCOPE 1. Safe staffing for nursing in accident and emergency departments Background 2. The National Institute for
More information